Anthony Atala, MD, is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine. Seventeen of his lab’s technologies have been translated to patients, including the first tissue-engineered organ for permanent implantation in a human. His research led to the discovery of a multipotent source of stem cells from amniotic fluid and placenta, advances in 3D printing of tissues and organs, and body-on-a-chip technologies. His work was twice listed among Time Magazine’s top 10 medical breakthroughs of the year, and he is a recipient of the Smithsonian Ingenuity Award. He has published over 900 journal articles, is the editor of 25 books, and holds over 250 national and international patents. Dr. Atala is a member of the National Academy of Medicine, the National Academy of Inventors, and the American Institute for Medical and Biological Engineering.Dr. Lim’s research interests encompass tissue engineering, biofabrication, regenerative engineering, and controlled drug delivery systems. Her work has been widely recognized, with over 150 peer-reviewed publications and numerous patents, some of which have been licensed to companies. Dr. Lim has been honored with prestigious awards such as the TERMIS International Fellow Award and KTERMS Award, highlighting her contributions to the field. Dr. Lim has delivered over 160 invited presentations worldwide and has played key roles in various academic and professional organizations, including serving as President of the Korea Tissue Engineering and Regenerative Medicine Society and as a TERMIS Fellow. Her editorial roles span several leading journals, including Tissue Engineering and Regenerative Medicine, where she has served as an Editorial Board Member and Associate Editor. Dr. Lim has held academic appointments at Wake Forest University School of Medicine, where she is currently a Professor in the Department of Regenerative Medicine.